The results showed that autophagy-related genes were mainly enriched in nonresponders and that the autophagy score was significantly increased in the nonresponders, which indicated that autophagy might play a role in the nonresponse to IFX therapy for RA and that DERL1 might be involved in autophagy regulation in this process. Here, DERL1 is linked to rheumatoid arthritis.